NCT02024997

Brief Summary

The overall aim of this study is to investigate a novel "dual instance" planning method to make use of the respiratory motion to improve pancreatic radiation therapy (RT) treatment planning. Specific Aim 1: Acquire patient abdominal MRI and CT at both deep inspiration (INSP) and expiration (EXP) positions and characterize the changes in geometric relationships between the INSP and EXP instances for tumor and normal tissues including stomach, duodenum and bowel. We hypothesize that INSP and EXP MRI and CT characterization will allow identification of patients who may benefit from the dual instance planning method. Specific Aim 2: Develop, investigate and evaluate plans based on free breathing, single instance breath hold, and the novel dual instance anatomical information. We hypothesize that use of the dual instance method will lead to improved plans, demonstrated by the ability to increase dose to the target, while maintaining the clinically-accepted normal tissue dose constraints.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at P25-P50 for early_phase_1 pancreatic-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2013

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 31, 2013

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Last Updated

October 30, 2014

Status Verified

October 1, 2014

Enrollment Period

1.7 years

First QC Date

December 18, 2013

Last Update Submit

October 29, 2014

Conditions

Keywords

Pancreatic malignancyRadiation Therapy

Outcome Measures

Primary Outcomes (1)

  • Compare magnetic resonance (MR) in different breath-hold phases to quantify respiration induced anatomic changes

    Baseline only (at least 3 days after CT simulation and up to 1 week after the initiation of radiation treatment)

Secondary Outcomes (1)

  • Modeling the feasibility of the dose escalation using respiration induced anatomic changes

    Baseline only (at least 3 days after CT simulation and up to 1 week after the initiation of radiation treatment)

Study Arms (1)

Abdominal MRI

EXPERIMENTAL

Subjects will undergo magnetic resonance imaging (MRI) with contrast. Magnetic resonance (MR)\_freebreathing scan will be acquired. MR\_inspiration scan will be acquired. MR\_expiration scan will be acquired.

Other: Magnetic Resonance Imaging (MRI)

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any patient with a biopsy proven diagnosis of malignancy involving the pancreas to be treated with radiation therapy
  • Age \>18 years
  • Ability to understand and the willingness to sign a written informed consent document
  • Creatinine or creatinine clearance of \<1.5 times the upper limit of normal or \>45 mL/min/1.73m2 for patients with creatinine levels above normal. Modification of Diet in Renal Disease (MDRD) formula was used to calculate the creatinine level

You may not qualify if:

  • Patients who are currently receiving any investigational agents
  • Unable to undergo MRIs
  • Patients with late stage kidney disease or who have had a liver transplant
  • Individuals who are allergic to animal dander or have asthma that may be enflamed by proximity to animals will be excluded as the scans will take place in a facility where animal research is also performed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cedars-Sinai Medical Center

Los Angeles, California, 90048, United States

Location

MeSH Terms

Conditions

Pancreatic Neoplasms

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Wensha Yang, Ph.D.

    Cedars-Sinai Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 18, 2013

First Posted

December 31, 2013

Study Start

January 1, 2013

Primary Completion

September 1, 2014

Last Updated

October 30, 2014

Record last verified: 2014-10

Locations